| Compatibility of drugs administered as Y-site infusion in intensive care units: A systematic review GC Lao, MR Reyes, JR Turet, MP Dot, DS Muner, CL Cabezas Medicina Intensiva (English Edition) 44 (2), 80-87, 2020 | 34 | 2020 |
| Safety and tolerability of more than six days of tedizolid treatment M Mensa Vendrell, M Tasias Pitarch, M Salavert Lletí, E Calabuig Muñoz, ... Antimicrobial Agents and Chemotherapy 64 (7), 10.1128/aac. 00356-20, 2020 | 32 | 2020 |
| Compatibilidad de los fármacos administrados en «Y» en las unidades de cuidados intensivos: revisión sistemática GC Lao, MR Reyes, JR Turet, MP Dot, DS Muner, CL Cabezas Medicina intensiva 44 (2), 80-87, 2020 | 8 | 2020 |
| Paralytic ileus and syndrome of inappropriate antidiuretic hormone secretion potentially due to an interaction between vincristine and voriconazole/posaconazole G Castells, M Rodríguez-Reyes, C Chaguaceda, E Carcelero, ... American Journal of Therapeutics 26 (6), e722-e723, 2019 | 2 | 2019 |
| Retreatment with full-dose cytarabine in a patient with previous neurological toxicity NM Casasnovas, A Manzaneque, A Muntañola, G Castells Journal of Oncology Pharmacy Practice 28 (7), 1634-1636, 2022 | | 2022 |
| 4CPS-234 Impact of an intensive monitoring programme on methotrexate elimination C Sebastián, G Castells, A Manzaneque, F Salazar, M Rodrigo, N Meca, ... European Journal of Hospital Pharmacy 29 (Suppl 1), A107-A108, 2022 | | 2022 |
| 5PSQ-095 Analysis of the toxicities associated with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia G Garreta, A Manzaneque, P Velez, M Giralt, G Castells, P Arcenillas, ... European Journal of Hospital Pharmacy 27 (Suppl 1), A193-A194, 2020 | | 2020 |
| 4CPS-185 Administration of oral anticancer drugs for patients with swallowing difficulties N Meca, A Manzaneque, G Castells, G Garreta, C Sebastián, I Parés, ... European Journal of Hospital Pharmacy 27 (Suppl 1), A135-A135, 2020 | | 2020 |
| 4CPS-113 Experience with braf and mek inhibitors in the treatment of metastasic melanoma in a third-level university hospital AC Escoda, G Castells, E Carcelero, G Riu European Journal of Hospital Pharmacy 25 (Suppl 1), A94-A95, 2018 | | 2018 |
